Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1966 2
1967 2
1968 1
1969 4
1971 2
1972 1
1973 3
1974 2
1975 6
1976 4
1977 7
1978 1
1979 2
1980 7
1981 6
1982 7
1983 7
1984 8
1985 7
1986 7
1987 26
1988 11
1989 28
1990 44
1991 39
1992 47
1993 42
1994 44
1995 31
1996 49
1997 40
1998 84
1999 42
2000 56
2001 56
2002 74
2003 98
2004 74
2005 81
2006 74
2007 78
2008 85
2009 118
2010 74
2011 61
2012 71
2013 72
2014 77
2015 76
2016 68
2017 59
2018 63
2019 82
2020 69
2021 98
2022 102
2023 97
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

2,337 results

Results by year

Filters applied: . Clear all
Page 1
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Provan D, et al. Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812. Blood Adv. 2019. PMID: 31770441 Free PMC article.
Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. ...
Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune …
Clinical updates in adult immune thrombocytopenia.
Lambert MP, Gernsheimer TB. Lambert MP, et al. Blood. 2017 May 25;129(21):2829-2835. doi: 10.1182/blood-2017-03-754119. Epub 2017 Apr 17. Blood. 2017. PMID: 28416506 Free PMC article. Review.
Immune thrombocytopenia (ITP) occurs in 2 to 4/100 000 adults and results in variable bleeding symptoms and thrombocytopenia. ...
Immune thrombocytopenia (ITP) occurs in 2 to 4/100 000 adults and results in variable bleeding symptoms and thrombocytopenia. …
How we treat primary immune thrombocytopenia in adults.
Liu XG, Hou Y, Hou M. Liu XG, et al. J Hematol Oncol. 2023 Jan 19;16(1):4. doi: 10.1186/s13045-023-01401-z. J Hematol Oncol. 2023. PMID: 36658588 Free PMC article. Review.
Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder characterized by decreased platelet counts and an increased risk of bleeding. ...The diagnosis remains a clinical exclusion of other causes of thrombocytopenia. Treatment is not required e …
Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder characterized by decreased platelet counts and an incre …
Adult Evans' Syndrome.
Michel M. Michel M. Hematol Oncol Clin North Am. 2022 Apr;36(2):381-392. doi: 10.1016/j.hoc.2021.12.004. Epub 2022 Mar 11. Hematol Oncol Clin North Am. 2022. PMID: 35282950 Review.
Evans syndrome (ES) is a rare immune disorder defined as the simultaneous or sequential occurrence in a single patient of immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA) autoimmune neutropenia (AIN). ...
Evans syndrome (ES) is a rare immune disorder defined as the simultaneous or sequential occurrence in a single patient of immune thromboc …
Treatment of drug-induced immune thrombocytopenias.
Marini I, Uzun G, Jamal K, Bakchoul T. Marini I, et al. Haematologica. 2022 Jun 1;107(6):1264-1277. doi: 10.3324/haematol.2021.279484. Haematologica. 2022. PMID: 35642486 Free PMC article. Review.
Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. ...Immune-mediated thrombocytopenia, on the other hand, involves the formation of antibodies that react to platelet-specific glycoprotein complexes, as …
Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. ...Immune-mediated …
Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems.
Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Wang L, et al. Front Immunol. 2022 Feb 10;13:833424. doi: 10.3389/fimmu.2022.833424. eCollection 2022. Front Immunol. 2022. PMID: 35222423 Free PMC article. Review.
According to the researches conducted during the nearly 40 years, it has been found that this bacterium is associated with a natural history of many upper gastrointestinal diseases. Epidemiological data show an increased incidence of autoimmune disorders with or after infe …
According to the researches conducted during the nearly 40 years, it has been found that this bacterium is associated with a natural history …
Pathogenesis of immune thrombocytopenia.
Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Audia S, et al. Autoimmun Rev. 2017 Jun;16(6):620-632. doi: 10.1016/j.autrev.2017.04.012. Epub 2017 Apr 17. Autoimmun Rev. 2017. PMID: 28428120 Review.
Immune thrombocytopenia (ITP) is a rare autoimmune disease due to an abnormal T cell response, notably supported by splenic T follicular helper cells, that stimulates the proliferation and differentiation of autoreactive B cells. ...Macrophages contribute to the per …
Immune thrombocytopenia (ITP) is a rare autoimmune disease due to an abnormal T cell response, notably supported by splenic T …
Immune thrombocytopenia.
Kistangari G, McCrae KR. Kistangari G, et al. Hematol Oncol Clin North Am. 2013 Jun;27(3):495-520. doi: 10.1016/j.hoc.2013.03.001. Hematol Oncol Clin North Am. 2013. PMID: 23714309 Free PMC article. Review.
Immune thrombocytopenia (ITP) is a common hematologic disorder characterized by isolated thrombocytopenia. ...
Immune thrombocytopenia (ITP) is a common hematologic disorder characterized by isolated thrombocytopenia. ...
Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia.
Sun S, Urbanus RT, Ten Cate H, de Groot PG, de Laat B, Heemskerk JWM, Roest M. Sun S, et al. Cells. 2021 Dec 1;10(12):3386. doi: 10.3390/cells10123386. Cells. 2021. PMID: 34943895 Free PMC article. Review.
Autoimmune disorders are often associated with low platelet count or thrombocytopenia. ...Here, we present an overview of the reported molecular causes and consequences of IIT in the most common forms of autoimmune disorders. These include idiopathic …
Autoimmune disorders are often associated with low platelet count or thrombocytopenia. ...Here, we present an overview of the …
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R, Chaturvedi S. Kohli R, et al. Hamostaseologie. 2019 Aug;39(3):238-249. doi: 10.1055/s-0039-1683416. Epub 2019 Mar 13. Hamostaseologie. 2019. PMID: 30868551 Review.
Immune thrombocytopenia (ITP) occurs with an incidence rate of 1.6 to 3.9 per 100,000 patient-years, which increases with age and has a slight female preponderance. ...ITP is asymptomatic in some patients; however, when present, bleeding is the most common symptom and can …
Immune thrombocytopenia (ITP) occurs with an incidence rate of 1.6 to 3.9 per 100,000 patient-years, which increases with age and has …
2,337 results